Banque Pictet & Cie SA Boosts Holdings in Colgate-Palmolive (NYSE:CL)

Banque Pictet & Cie SA raised its stake in Colgate-Palmolive (NYSE:CL - Free Report) by 4.6% in the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 181,840 shares of the company's stock after acquiring an additional 8,057 shares during the quarter. Banque Pictet & Cie SA's holdings in Colgate-Palmolive were worth $16,531,000 as of its most recent SEC filing.

A number of other hedge funds also recently made changes to their positions in CL. V Square Quantitative Management LLC grew its position in Colgate-Palmolive by 1.7% during the 4th quarter. V Square Quantitative Management LLC now owns 15,598 shares of the company's stock worth $1,418,000 after acquiring an additional 266 shares during the last quarter. Farmers & Merchants Trust Co of Chambersburg PA grew its holdings in shares of Colgate-Palmolive by 34.7% during the fourth quarter. Farmers & Merchants Trust Co of Chambersburg PA now owns 970 shares of the company's stock worth $88,000 after purchasing an additional 250 shares during the last quarter. Asset Management One Co. Ltd. increased its stake in shares of Colgate-Palmolive by 4.3% in the fourth quarter. Asset Management One Co. Ltd. now owns 392,938 shares of the company's stock valued at $36,076,000 after buying an additional 16,036 shares during the period. Avestar Capital LLC raised its holdings in Colgate-Palmolive by 14.4% in the 4th quarter. Avestar Capital LLC now owns 5,142 shares of the company's stock valued at $467,000 after buying an additional 649 shares during the last quarter. Finally, Ingalls & Snyder LLC boosted its position in Colgate-Palmolive by 1.2% during the 4th quarter. Ingalls & Snyder LLC now owns 23,557 shares of the company's stock worth $2,142,000 after buying an additional 282 shares during the period. 80.41% of the stock is currently owned by institutional investors and hedge funds.

Wall Street Analyst Weigh In

Several equities analysts have recently issued reports on CL shares. StockNews.com downgraded shares of Colgate-Palmolive from a "buy" rating to a "hold" rating in a research note on Thursday, January 9th. TD Cowen lowered their target price on Colgate-Palmolive from $110.00 to $100.00 and set a "buy" rating for the company in a research report on Wednesday, January 8th. Royal Bank of Canada reaffirmed a "sector perform" rating and set a $101.00 target price on shares of Colgate-Palmolive in a report on Wednesday, January 29th. Wells Fargo & Company lowered their price objective on Colgate-Palmolive from $92.00 to $83.00 and set an "underweight" rating for the company in a research report on Tuesday, January 7th. Finally, Piper Sandler cut their price objective on Colgate-Palmolive from $121.00 to $112.00 and set an "overweight" rating on the stock in a research note on Monday, January 6th. One equities research analyst has rated the stock with a sell rating, ten have given a hold rating and twelve have issued a buy rating to the company's stock. Based on data from MarketBeat.com, Colgate-Palmolive currently has an average rating of "Hold" and an average target price of $101.16.

Colgate-Palmolive Stock Up 0.4 %

CL traded up $0.37 during midday trading on Tuesday, reaching $86.41. 3,827,625 shares of the company were exchanged, compared to its average volume of 4,960,612. Colgate-Palmolive has a one year low of $83.70 and a one year high of $109.30. The company has a debt-to-equity ratio of 9.46, a quick ratio of 0.26 and a current ratio of 0.41. The company's fifty day moving average price is $89.39 and its 200 day moving average price is $96.22. The company has a market cap of $70.60 billion, a price-to-earnings ratio of 24.55, a price-to-earnings-growth ratio of 4.12 and a beta of 0.44.

Colgate-Palmolive (NYSE:CL - Get Free Report) last released its quarterly earnings results on Friday, January 31st. The company reported $0.91 EPS for the quarter, beating analysts' consensus estimates of $0.90 by $0.01. Colgate-Palmolive had a return on equity of 477.77% and a net margin of 14.38%. During the same period last year, the company posted $0.87 earnings per share. As a group, analysts expect that Colgate-Palmolive will post 3.73 EPS for the current year.

Colgate-Palmolive Announces Dividend

The company also recently declared a quarterly dividend, which was paid on Friday, February 14th. Investors of record on Tuesday, January 21st were issued a dividend of $0.50 per share. This represents a $2.00 annualized dividend and a yield of 2.31%. The ex-dividend date of this dividend was Tuesday, January 21st. Colgate-Palmolive's dividend payout ratio (DPR) is presently 56.82%.

Colgate-Palmolive Company Profile

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.